|
|
|
SENSEX
|
|
89.83
|
0.12%
|
73738.45
|
|
|
NIFTY
|
|
31.60
|
0.14%
|
22368.00
|
|
|
Nasdaq
|
|
169.30
|
1.11%
|
15451.31
|
|
|
Nikkei 225
|
|
370.26
|
1.00%
|
37438.61
|
|
|
FTSE 100
|
|
128.02
|
1.62%
|
8023.87
|
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Divis Labs |
BSE Code |
532488
|
ISIN Demat |
INE361B01024
|
Book Value (Rs) |
488.01
|
|
NSE Code |
DIVISLAB
|
Dividend Yield % |
0.80
|
Market Cap (Rs) |
1001267.84
|
|
TTM PE(x) |
73.42
|
TTM EPS(Rs) |
51.37
|
Face Value(Rs.) |
2
|
|
|
|
|
|
|
Incorporation Year
|
12-10 1990
|
Registered Office
|
1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli, Hyderabad, Telangana-500032 .
|
ISINNO
|
INE361B01024
|
Phone
|
040 66966300
|
E-mail
|
mail@divislabs.com |
URL
|
www.divislabs.com |
Industry
|
Pharmaceuticals & Drugs
|
Chairman
|
Ramesh BV Nimmagadda
|
Managing Director
|
Murali K Divi
|
Company Secretary
|
Satish Choudhury
|
Listing
|
BSE,NSE,MCX
|
|
|
|
|
|
|
|
|
|
|
|